Vírus Epstein-Barr associado ao Linfoma de Hodgkin clássico: um estudo de casos
DOI:
https://doi.org/10.34019/1982-8047.2023.v49.43242Keywords:
Epstein-Barr virus, Hodgkin’s Lymphoma, PrognosisAbstract
Introduction: The expression of EBV (Epstein-Barr virus) presence in Hodgkin/Reed-Sternberg cells and its association with the prognosis remains controversial. Objectives: The present study aims to identify the occurrence of EBV in patients with Hodgkin's lymphoma and to associate the clinical outcome with positivity in patients. Methods: To determine the presence of EBV, a paraffin-embedded tissue biopsy was performed and analysed through hybridization for EBV-encoded RNA and immunohistochemistry for viral latent membrane protein (LMP-1). The procedure was conducted by a hematopathologist blinded to the outcome of EBV status in cHL tumour cells. Prognostic factors of the International Prognosis Score for advanced stage and risk factors of the German Hodgkin Study Group for limited stage were correlated with EBV status. Results: Slides of biopsy were retrieved from 29 patients diagnosed with Hodgkin's Lymphoma. The mixed cellularity histological subtype showed statistic association with EBV-positive status (p= 0.02). In addition, EBV-positive cHL status was more common in patients aged 45 years or older (p= 0.07). There was a trend suggesting improved event-free survival (p=0.07), but it did not reach levels of statistical significance. Conclusion: Although it is related to mixed cellularity histological subtype, the prognosis association of cHL and EBV-status tumour cells has not been clearly established in the present study.
Downloads
References
Instituto Nacional de Câncer José Alencar Gomes da Silva (BR). Estimativa 2018: incidência de câncer no Brasil. Rio de Janeiro: INCA; 2018.
Shanbhag S, Ambinder RF. Hodgkin lymphoma: a review and update on recent progress. CA Cancer J Clin. 2018; 68(2):116-32.
Ferlay J, Colombet M, Soerjomataram I, Dyba T, Randi G, Bettio M et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries and 25 major cancers in 2018. Eur J Cancer. 2018; 103:356-87.
Weiss LM, Chen YY, Liu XF, Shibata D. Epstein-Barr virus and Hodgkin's disease: a correlative in situ hybridization and polymerase chain reaction study. Am J Pathol. 1991; 139(6):1259-65.
Kapatai G, Murray P. Contribution of the Epstein Barr virus to the molecular pathogenesis of Hodgkin lymphoma. J Clin Pathol. 2007; 60:1342-9.
Jarrett RF. Risk factors for Hodgkin's lymphoma by EBV status and significance of detection of EBV genomes in serum of patients with EBV-associated Hodgkin's lymphoma. Leuk Lymphoma. 2003; 44 Suppl 3:S27-32.
Keegan TH, Glaser SL, Clarke CA, Gulley ML, Craig FE, Di Giuseppe JA et al. Epstein-Barr virus as a marker of survival after Hodgkin's lymphoma: a population-based study. J Clin Oncol. 2005; 23(30):7604-13.
Engel M EM, Close P, Hartley P, Pallesen G, Sinclair-Smith C. Improved prognosis of Epstein-Barr virus associated childhood Hodgkin's lymphoma: study of 47 South African cases. J of Clin Pathol. 2000; 53:182-6.
Vassallo J MK, Traina F, de Souza CA, Lorand-Metze I. Expression of Epstein-Barr virus in classical Hodgkin’s lymphomas in Brazilian adult patients. Hematologica. 2001; 86:1227-8.
Instituto Brasileiro de Geografia e Estatística (BR). Estatística: 2018 [Internet]. 2018 [citado em 2019 jun. 5]. Disponível em: https://www.ibge.gov.br/.
Carbone PP, Kaplan HS, Musshoff K, Smithers DW, Tubiana M. Report of the Committee on Hodgkin's Disease Staging Classification. Cancer Res. 1971; 31(11):1860-1.
Hasenclever D, Diehl V. A prognostic score for advanced Hodgkin's disease: International Prognostic Factors Project on Advanced Hodgkin's Disease. N Engl J Med. 1998; 339(21):1506-14.
Josting A, Franklin J, May M, Koch P, Beykirch MK, Heinz J et al. New prognostic score based on treatment outcome of patients with relapsed Hodgkin's lymphoma registered in the database of the German Hodgkin's lymphoma study group. J Clin Oncol. 2002; 20(1):221-30.
Cheson BD, Pfistner B, Juweid ME, Gascoyne RD, Specht L, Horning SJ et al. Revised response criteria for malignant lymphoma. J Clin Oncol. 2007; 25(5):579-86. doi: 10.1200/JCO.2006.09.2403
Alaggio R, Amador C, Anagnostopoulos I, Attygalle AD, Araujo IBO, Berti E et al. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms. Leukemia. 2022; 36:1720-48. Doi: 10.1038/s41375-022-01620-2
Qi ZL, Han XQ, Hu J, et al. Comparison of three methods for the detection of Epstein-Barr virus in Hodgkin's lymphoma in paraffin-embedded tissues. Mol Med Rep. 2013; 7(1):89-92.
Gulley ML, Glaser SL, Craig FE et al. Guidelines for interpreting EBER in situ hybridization and LMP1 immunohistochemical tests for detecting Epstein-Barr virus in Hodgkin lymphoma. Am J Clin Pathol. 2002; 117(2):259-67.
Jarrett RF, Stark GL, White J, et al. Impact of tumor Epstein-Barr virus status on presenting features and outcome in age-defined subgroups of patients with classic Hodgkin lymphoma: a population-based study. Blood. 2005; 106(7):2444-51.
Naresh NK, Jhonson J, Srinivas V, et al. Epstein-Barr virus association in classical Hodgkin's disease provides survival advantage to patients and correlates with higher expression of proliferation markers in Reed-Sternberg cells. Ann Oncol. 2000; 11:91-96.
Kwon JM, Park YH, Kang JH et al. The effect of Epstein–Barr virus status on clinical outcome in Hodgkin’s lymphoma. Ann Hematol. 2006; 85:463-8.
Glavina-Durdov M, Jakic-Razmovic J, Capkun V, Murray P. Assessment of the prognostic impact of the Epstein-Barr virus-encoded latent membrane protein-1 expression in Hodgkin's disease. Britsh J Cancer. 2001; 84:1227-34.
Morente MM, Piris MA, Abraira V, et al. Adverse clinical outcome in Hodgkin's Disease is associated with loss of retinoblastoma protein expression, high Ki67 proliferation index, and absence of Epstein-Barr virus-latent membrane protein 1 expression. Blood. 1997; 90:2429-36.
Keresztes K, Miltenyi Z, Bessenyei B et al. Association between the Epstein-Barr Virus and Hodgkin’s Lymphoma in the North-Eastern part of Hungary: effects on therapy and survival. Acta Haematol. 2006; 116:101-7.
Dinand V, Dawar R, Arya LS et al. Hodgkin’s lymphoma in Indian children: prevalence and significance of Epstein-Barr virus detection in Hodgkin’s and Reed-Sternberg cells. Eur J Cancer. 2007; 43(1):161-8.
Fatima S, Ahmed R, Ahmed A. Hodgkin lymphoma in Pakistan: an analysis of subtypes and their correlation with Epstein Barr virus. Asian Pac J Cancer Prev. 2011; 12(6):1385-8.
Herling M, Rassidakis GZ, Medeiros LJ et al. Expression of Epstein-Barr virus latent membrane protein-1 in Hodgkin and Reed-Sternberg cells of classical Hodgkin's lymphoma: associations with presenting features, serum interleukin 10 levels, and clinical outcome. Clin Cancer Res. 2003; 9(6):2114-20.
Axdorph U, Porwit-MacDonald A, Sjöberg J et al. Epstein-Barr virus expression in Hodgkin's disease in relation to patient characteristics, serum factors and blood lymphocyte function. Br J Cancer. 1999; 81(7):1182-7.
Begi´c V, Kora´c P, Gašparov S, Rozman M, Simicic P, Zidovec-Lepej S. Molecular characterisation of Epstein–Barr Virus in Classical Hodgkin. Lymphoma. Int J Mol Sci. 2022; 23:15635.
Murray PG, Young LS. An etiological role for the Epstein-Barr virus in the
pathogenesis of classical Hodgkin lymphoma. Blood. 2019; 134(7):591-6.
Bednarska k, Chowdhury R, Tobin JWD, Swain F, Keane C, Boyle S et al. Epstein–Barr virus-associated lymphomas decoded. Br J Haematol. 2023; 00:1-19.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Julia Diniz Ferreira, Graziela Toledo Costa Mayrink , Kelli Borges dos Santos, Abrahão Elias Hallack Neto
This work is licensed under a Creative Commons Attribution 4.0 International License.
Cessão de Primeira Publicação à HU Revista
Os autores mantém todos os direitos autorais sobre a publicação, sem restrições, e concedem à HU Revista o direito de primeira publicação, com o trabalho licenciado sob a Licença Creative Commons Attribution que permite o compartilhamento irrestrito do trabalho, com reconhecimento da autoria e crédito pela citação de publicação inicial nesta revista, referenciando inclusive seu DOI.
